LISAvienna: December e-newsletter features current highlights

Success stories, events and insights regarding funding opportunities – this is what the LISAvienna e-newsletter offers ten times a year. Subscribe now!

Vienna invests in innovation in the life sciences sector. This time, our newsletter informs you about Boehringer Ingelheim, strengthening its cancer R&D in Vienna, new ERC grants at CeMM, a new product from Lexogen, new patent applications filed by Sanochemia, exciting new publications and projects as well as this year’s winners in the life sciences category of the Mercur 2015 Award at WKO Vienna. An even broader view about current developments in the life sciences in Vienna is available in LISAvienna’s online news collection.

Events, trade fairs and a link to the new article published in the context of our media collaboration with Chemiereport are also included in the current edition of our e-newsletter. Furthermore, we invite you to explore our new link lists on funding and private equity as additional resources. Moreover, get information on the up-to-date funding opportunities including new calls for projects and deadlines!

Read the December e-newsletter >>

Subscribe for free >>

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)